Earnings release
Page 1
RNS Number : 5387I Spire Healthcare Group PLC 14 May 2025 Spire Healthcare Group plc ('Spire Healthcare', 'the Group' or 'the Company') 14 May 2025 Ahead of its Annual General Meeting later today, Spire Healthcare Group plc (LSE: SPI), a leading independenthealthcare group in the UK, issues the following trading statement for the period 1 January 2025 to 30 April 2025 ("theperiod"). The Board is pleased to confirm that performance in the period has been in line with our expectations and the 2025 guidanceprovided. Furthermore, our on-going transformation programme, which is expected to deliver at least £30m in efficienciesduring FY25, remains on track with benefits weighted towards the second half of the year. We confirm, as a business with 100% direct UK revenue exposure, we do not currently anticipate any material cost or supplychain impacts as a result of recent tariff announcements. Spire has also been recently named a founding supplier as part of the Government's National Strategic Supplier Relationshipprogramme. We look forward to working with the NHS to build a strong, long term and sustainable footing for increasedNHS commissioning. Upcoming events Primary Care roundtable 20 May: Investor and analyst event, hosted by our Primary Care Executive Management Team.Taking place on 20 May at 9am as a hybrid event. To attend in-person please contact investors@spirehealthcare.com or forthose who wish to join virtually please register using the following link and webinar ID 812 2509 3179: https://storm-virtual-uk.zoom.us/webinar/register/WN_KjAnWLn5T4KCO-YcZnzlng Notice of interim results 31 July: results for the six-month period ending 30 June 2025 will be announced on Thursday, 31July 2025. A link to the webcast will be provided in due course through our website athttps://www.investors.spirehealthcare.com For further information please contact: Spire Healthcare: investors@spirehealthcare.com Amie Gramlick: Director of Investor Relations & Commercial Finance Instinctif Partners: spire@instinctif.com Julian Walker Tim Pearson Registered Office and Head Office: Spire Healthcare Group plc 3 Dorset Rise London EC4Y 8EN Registered number 09084066 2025-05-14 13:51 AGM Trading Statement https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=7462489&lang=en-GB&companycode=uk-spi&v= 1/2
Page 2
About Spire Healthcare Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients. Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand. Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good,' 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland. Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END TSTUOORRVVUVAUR 2025-05-14 13:51 AGM Trading Statement https://tools.eurolandir.com/tools/Pressreleases/GetPressRelease/?ID=7462489&lang=en-GB&companycode=uk-spi&v= 2/2